Apitope News

Latest Press Releases

Apitope grows operations with move to St Brandon’s House, Bristol UK

October 1, 2010

Bristol, England / Hasselt, Belgium – 1st October 2010 – Apitope International N.V., the biopharmaceutical company developing peptide therapies for autoimmune diseases, announced today that it has relocated its UK subsidiary HQ to larger premises at St Brandon’s House in Bristol, England as a result of significant growth in Apitope’s business and staff. St Brandon’s…

Details

Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment

May 18, 2010

Bristol, UK / Hasselt, Belgium – 18th May 2010 – Apitope, the European Biotech Company developing therapeutic peptides to treat autoimmune and allergic diseases, today announced the start of its second phase 1 clinical trial of ATX-MS-1467, in patients with Multiple Sclerosis (MS). MS is a chronic, inflammatory condition of the nervous system and is…

Details